Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 100.00% is 156% above its 5-year average of 39.11%, near the high end of its 5-year range (-981.69%–100.00%).
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
100.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
39.11%
GROSS MARGIN AVG 10Y
-229.54%
GROSS MARGIN AVG 15Y
-173.37%
GROSS MARGIN AVG 20Y
-43.24%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
+155.66%
CURRENT VS 10Y AVG
+143.57%
CURRENT VS 15Y AVG
+157.68%
CURRENT VS 20Y AVG
+331.27%
SECTOR MEDIAN · HEALTHCARE
40.44%
median of 789 covered companies
CURRENT VS SECTOR MEDIAN
+147.28%
vs the sector median at left
Inovio Pharmaceuticals, Inc.
Market Cap
$79.46M
Gross Margin
100.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
39.11%
Market Cap
$78.06M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
Market Cap
$77.93M
Gross Margin
77.06%
TTM Avg
74.09%
3Y Avg
74.09%
5Y Avg
72.46%
Market Cap
$77.15M
Gross Margin
-102.47%
TTM Avg
-54.48%
3Y Avg
-12.40%
5Y Avg
10.21%
Market Cap
$82.15M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Inovio Pharmaceuticals, Inc. (INO) | $79.46M | 100.00% | 0.00% | 0.00% | 39.11% |
| Citius Oncology, Inc. (CTOR)vs › | $79.96M | 0.00% | 0.00% | 0.00% | 0.00% |
| Nutriband Inc. (NTRB)vs › | $80.78M | 33.14% | 30.24% | 34.48% | 35.28% |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $78.06M | 100.00% | 100.00% | 100.00% | 100.00% |
| Pulmonx Corporation (LUNG)vs › | $77.93M | 77.06% | 74.09% | 74.09% | 72.46% |
| Hyperfine, Inc. (HYPR)vs › | $77.39M | 51.41% | 47.75% | 37.98% | -14.72% |
| Sera Prognostics, Inc. (SERA)vs › | $77.15M | -102.47% | -54.48% | -12.40% | 10.21% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $82.15M | 0.00% | 0.00% | 0.00% | 0.00% |
| LENSAR Inc (LNSR)vs › | $82.29M | 47.96% | 47.37% | 50.31% | 51.06% |
| SkinHealth Systems Inc. (SKIN)vs › | $76.14M | 66.34% | 59.91% | 56.70% | 58.64% |
Gross Margin
100.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 100.00% |
| 2024-12-31 | -563.14% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | -722.36% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | -70.70% |
| 2023-09-30 | 100.00% |
| 2023-06-30 | 100.00% |
| 2023-03-31 | -902.34% |
| 2022-12-31 | -981.69% |
| 2022-09-30 | 100.00% |
| 2022-06-30 | 100.00% |
| 2022-03-31 | 100.00% |
| 2021-12-31 | -64.36% |
| 2021-09-30 | 100.00% |
| 2021-06-30 | 100.00% |
| 2021-03-31 | 100.00% |
| 2020-12-31 | -371.32% |
| 2020-09-30 | 100.00% |
| 2020-06-30 | -8274.87% |
| 2020-03-31 | 100.00% |
| 2019-12-31 | -7093.14% |
| 2019-09-30 | -2107.64% |
| 2019-06-30 | -16473.87% |
| 2019-03-31 | -761.86% |
| 2018-12-31 | -953.52% |
| 2018-09-30 | -992.12% |
| 2018-06-30 | 8.12% |
| 2018-03-31 | -1506.76% |
| 2017-12-31 | -180.42% |
| 2017-09-30 | -864.64% |
| 2017-06-30 | -16.98% |
| 2017-03-31 | -136.53% |
| 2016-12-31 | -180.85% |
| 2016-09-30 | -115.15% |
| 2016-06-30 | -216.43% |
| 2016-03-31 | -124.28% |
| 2015-12-31 | -162.85% |
| 2015-09-30 | 33.53% |
| 2015-06-30 | -215.67% |
| 2015-03-31 | -82.45% |
| 2014-12-31 | -276.23% |
| 2014-09-30 | -281.33% |
| 2014-06-30 | -152.71% |
| 2014-03-31 | -248.89% |
| 2013-12-31 | -268.12% |
| 2013-09-30 | 42.67% |
| 2013-06-30 | -461.48% |
| 2013-03-31 | -251.50% |
| 2012-12-31 | -291.52% |
| 2012-09-30 | -481.76% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | 100.00% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 100.00% |
| 2010-12-31 | 100.00% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | 100.00% |
| 2010-03-31 | 100.00% |
| 2009-12-31 | 100.00% |
| 2009-09-30 | 100.00% |
| 2009-06-30 | 100.00% |
| 2009-03-31 | 100.00% |
| 2008-12-31 | 100.00% |
| 2008-09-30 | 100.00% |
| 2008-06-30 | 100.00% |
| 2008-03-31 | 100.00% |
| 2007-12-31 | 100.00% |
| 2007-09-30 | 100.00% |
| 2007-06-30 | 88.65% |
| 2007-03-31 | 88.84% |
| 2006-12-31 | 85.31% |
| 2006-09-30 | 90.23% |
| 2006-06-30 | 91.51% |
| 2006-03-31 | 91.94% |
| 2005-12-31 | 75.13% |
| 2005-09-30 | 92.24% |
| 2005-06-30 | 98.09% |
| 2005-03-31 | 100.00% |
| 2004-12-31 | 100.00% |
| 2004-09-30 | 100.00% |
| 2004-06-30 | 100.00% |
| 2004-03-31 | 100.00% |
| 2003-12-31 | 100.00% |
| 2003-09-30 | 100.00% |
| 2003-06-30 | 100.00% |
| 2003-03-31 | 100.00% |
| 2002-12-31 | -315.44% |
| 2002-09-30 | 100.00% |
